AP Investigation: Insulin Pumps Have High Number of injuriesWhen it comes to medical devices, none have had more reported problems over the last decade than insulin pumps, a product that's used by hundreds of thousands of diabetics around the world, many of them children.
FDA Seizes Thousands Of Documents From E-Cigarette Maker JuulThe Food and Drug Administration (FDA) recently staged a surprise inspection and seized "over a thousand documents" at the headquarters of Juul, the nation's leading e-cigarette manufacturer.
Almond Milk Recalled Because It May Contain Real MilkThe product is safe to consume unless you have a milk allergy or sensitivity, the FDA says.
Kirk Urges Prompt FDA Approval Of Nasal Version Of NarcanU.S. Sen. Mark Kirk was pressuring the Food and Drug Administration to quickly approve a nasal spray that can treat heroin overdoses in an emergency.
Former Lyons Cop Gets 5 Years For ExtortionA former Lyons police officer has been sentenced to 5 years in prison, for using his badge to steal contraband cigarettes from dealers he was arresting.
Durbin Seeks Federal Regulation Of E-CigarettesU.S. Sen. Dick Durbin (D-Ill.) and others were calling on the U.S. Food and Drug Administration to crack down on what they say are efforts to market electronic cigarettes to children.
Feds Seize Food At Streamwood Warehouse
FDA Examining Link Between Food Dyes, HyperactivityThe U.S. Food and Drug Administration has begun looking into the possible link between food coloring and hyperactive behavior in children.
FDA Approves Skin Cancer Drug Shown To Extend SurvivalThe Food and Drug Administration on Friday approved the first drug shown to extend survival in people with late-stage melanoma, the deadliest form of skin cancer.
FDA Pulls 500 Cold & Allergy Drugs From MarketThe U.S. Food and Drug Administration wants you to check your medicine cabinet to see if you have any of more than 500 medicines it is pulling off the market.
Patients, Doctors Hope FDA Doesn't Ban Cancer DrugDesperate patients and their doctors have been battling a recommendation to revoke approval of the breast cancer drug Avastin, a move the FDA could make before the end of the year.